Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 1/20 | 0.50 |
| ▸ | FNTB | P49356 | 1/20 | 0.50 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | PCNA | P12004 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10567198 | 0.83 | CA2 (0.56) | CA2CAMK2ALMNANUDT1 | |
| SCHEMBL171877 | 0.83 | CTBP2 (0.48) | CTBP2LMNAHDAC4HDAC6NPC1 | |
| SCHEMBL14340565 | 0.83 | ALDH1A1 (0.48) | ALOX5LMNAHDAC4HDAC6NUDT1 | |
| SCHEMBL15920608 | 0.83 | HDAC4 (0.44) | CA2ALOX5HDAC4HDAC6NUDT1 | |
| SCHEMBL8143899 | 0.81 | CYP2D6 (0.46) | ALOX5HDAC4HDAC6NUDT1PARP1 | |
| SCHEMBL15920640 | 0.81 | CA1 (0.45) | CA2ALOX5HDAC4HDAC6RAB9A | |
| SCHEMBL3129879 | 0.81 | MEN1 (0.51) | NPC1 | |
| SCHEMBL14959151 | 0.81 | TDP1 (0.62) | CTBP2LMNAHDAC4HDAC6 | |
| SCHEMBL4052270 | 0.81 | NUDT1 (0.49) | ALOX5LMNAHDAC4HDAC6NUDT1 | |
| SCHEMBL29894648 | 0.81 | RAB9A (0.55) | CTBP2LMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046725-A2 | PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | Teva Pharmaceutical Industries Ltd. (IL) | 2009-04-15 | — | — | EP | claimed |
| US-20080183016-A1 | Process for the synthesis of O-desmethylvenlafaxine | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-07-31 | — | — | US | claimed |
| WO-2008013990-A2 | PROCESSES FOR THE SYNTHESIS OF O-DESMETHYLVENLAFAXINE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-01-31 | — | — | WO | claimed |
| WO-2002059177-A2 | POLY (HYDROXYAMINOETHERS) HAVING A LOW CHLORIDE CONTENT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-08-01 | — | — | WO | claimed |
| WO-2023028350-A1 | THERAPEUTIC COMPOSITIONS AND RELATED METHODS | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| US-9938415-B2 | Functionalised antifouling compounds and use thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-04-10 | — | — | US | disclosed |
| US-9481670-B2 | Triazine compounds | SPHAERA PHARMA PTE. LTD. (SG) | 2016-11-01 | — | — | US | disclosed |
| US-9481670-B2 | Triazine compounds | SPHAERA PHARMA PTE. LTD. (SG) | 2016-11-01 | — | — | US | disclosed |
| US-20160009926-A1 | FUNCTIONALISED ANTIFOULING COMPOUNDS AND USE THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-01-14 | — | — | US | disclosed |
| CN-103209969-B | Functionalized anti-fouling compound and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-11-25 | — | — | CN | disclosed |
| US-9169223-B2 | Functionalised antifouling compounds and use thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-10-27 | — | — | US | disclosed |
| US-8609699-B2 | Oxotetrahydrofuran-2-yl-benzimidazole derivative | MSD K.K. (JP) | 2013-12-17 | — | — | US | disclosed |
| US-20070015791-A1 | Serotonin and norepinephrine reuptake inhibitors and uses thereof | WYETH (US) | 2007-01-18 | — | — | US | disclosed |
| US-20070015828-A1 | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | WYETH (US) | 2007-01-18 | — | — | US | disclosed |
| US-20070015791-A1 | Serotonin and norepinephrine reuptake inhibitors and uses thereof | WYETH (US) | 2007-01-18 | — | — | US | disclosed |
| US-20070015828-A1 | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | WYETH (US) | 2007-01-18 | — | — | US | disclosed |
| US-20070015828-A1 | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | WYETH (US) | 2007-01-18 | — | — | US | disclosed |
| WO-2002059177-A2 | POLY (HYDROXYAMINOETHERS) HAVING A LOW CHLORIDE CONTENT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| WO-2002048234-A2 | EPOXY RESINS AND PROCESS FOR MAKING THE SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-06-20 | — | — | WO | disclosed |
| US-4283418-A | ANTIPLASMIN AND ANTITRYPSIN AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015828-A1 | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | SLC6A2, SLC6A3, SLC6A4 | CA2 4833/4885CAMK2A 3307/4885FNTA 2181/4885 |
| US-20080183016-A1 | Process for the synthesis of O-desmethylvenlafaxine | CYP2D6, CYP3A4, CYP4F3 | CA2 4346/4885CAMK2A 1251/4885FNTA 1202/4885 |
| US-20160009926-A1 | FUNCTIONALISED ANTIFOULING COMPOUNDS AND USE THEREOF | PFAS, ALKBH3, ITGA1 | CA2 2332/4885CAMK2A 4803/4885FNTA 78/4885 |
| US-20070015791-A1 | Serotonin and norepinephrine reuptake inhibitors and uses thereof | SLC6A2, SLC6A3, SLC6A4 | CA2 4817/4885CAMK2A 3178/4885FNTA 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.